Study evaluates airborne transmission risk of mpox compared to COVID-19 and smallpox
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Aug-2025 05:10 ET (15-Aug-2025 09:10 GMT/UTC)
A study by A*STAR Infectious Diseases Labs (A*STAR IDL) and A*STAR Institute of High Performance Computing (A*STAR IHPC) has assessed the airborne transmission risk of mpox compared to SARS-CoV-2 and smallpox. Using computational modelling and virological data, researchers found that mpox is significantly less likely to spread via respiratory aerosols in its current form. However, potential viral evolution underscores the need for continued surveillance. The study, published in The Lancet Microbe, highlights the value of interdisciplinary research in understanding infectious disease transmission.
Researchers from the BIRTE research group looked at how different fiscal policies contributed to reducing the carbon emissions, water use and food waste generated by food consumption. They concluded that a generalized increase in taxes on all products is not as effective as differential taxing or subsidising of each food category. They also stated the importance of designing different policies according to the objectives to be achieved.
A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both liver diseases and common diseases such as cancer and cardiovascular disease, according to the study published in The Journal of Hepatology.
A research group led by Associate Professor Takashi Kikuchi and Professor Wei Li from the Department of Pharmacognosy at the Faculty of Pharmaceutical Sciences, Toho University, along with Professor Atsushi Sugiyama from the Department of Pharmacology at the Faculty of Medicine and Industry-Academia Collaboration Advisor Katsuhiko Ito, has analyzed the chemical compounds of the roots of Codonopsis lanceolata (commonly known as “Tsuruninjin”) grown in Nagano Prefecture. Their findings have revealed the compounds of the plant and, in particular, demonstrated that its major compound, lancemaside A, exhibits vasodilatory effects, suggesting that Codonopsis lanceolata could be effectively utilized as a health-promoting material in the future.
This research was published in the academic journal Chemistry on January 6, 2025.